
Weekly Birth Control Patch | Twirla®
TWIRLA is a birth control patch for women with a BMI less than 30 kg/m 2 who can become pregnant. It contains two female hormones, a progestin called levonorgestrel, and an estrogen called ethinyl estradiol.
Contraceptive Patch | Twirla®
Introducing Twirla ® (levonorgestrel and ethinyl estradiol) transdermal system, the first and only combined hormonal once-weekly birth control patch delivering a low dose of estrogen. 1-5 Twirla is for use in women of reproductive potential with a BMI <30 kg/m 2 for whom a combined hormonal contraceptive is appropriate.
Use Twirla
TWIRLA is a birth control patch for women with a BMI less than 30 kg/m 2 who can become pregnant. It contains two female hormones, a progestin called levonorgestrel, and an estrogen called ethinyl estradiol.
Twirla Patch: Usage, Side Effects, Warnings - Drugs.com
2025年2月4日 · Twirla is a prescription medicine used as birth control to prevent pregnancy. Twirla is for use by women with a BMI less than 30 kg/m2 who can become pregnant. Twirla patches have been shown to have reduced effectiveness in women with a …
TWIRLA- levonorgestrel/ethinyl estradiol patch - DailyMed
2024年7月3日 · TWIRLA is a TDS designed with an active matrix core containing LNG and EE. TWIRLA delivers medication to the systemic circulation by absorption of LNG and EE through the skin. Absorption Following application of TWIRLA, both LNG and EE reach a plateau by 24 to 48 hours (Figures 5 and 6). Delivery of hormones is continuous over the 7 days of ...
Our Product – Agile
TWIRLA is a birth control patch for women with a BMI less than 30 kg/m 2 who can become pregnant. It contains two female hormones, a progestin called levonorgestrel, and an estrogen called ethinyl estradiol. TWIRLA may not be as effective in …
新型避孕药Twirla(左炔诺孕酮和炔雌醇贴片)获FDA批准上市
Twirla被指示为BMI <30kg/m2的具有生殖潜力的妇女的避孕方法,适合联合激素避孕的妇女。 使用限制 考虑在处方前Twirla对于BMI>25至<30kg/m2的女性有效性下降。Bw>30kg/m2的女性禁用Twirla。
FDA批准了Agile Therapeutics每周一次的避孕贴片Twirla
2020年2月17日 · Agile Therapeutics表示, FDA 已批准每周一次的避孕贴剂Twirla透皮系统上市,该系统可提供乙炔雌二醇和左炔诺孕酮的每日剂量。 此次批准基于III期 临床 试验SECURE的结果,该试验在2032名18岁及以上的健康女性中对Twirla进行了评估。 SECURE的研究人员David Portman表示:"Twirla是现有荷尔蒙避孕方法的重要补充,为美国女性提供每周一次的透皮选择,使雌激素水平与许多常用处方口服避孕药的标示剂量相符。 该批准是在最近的FDA咨询小 …
Twirla: Uses, Taking, Side Effects, Warnings - Medicine.com
Twirla is a birth control patch for women with a Body Mass Index (BMI) less than 30 kg/m2 who can become pregnant. It contains two female hormones, a progestin called levonorgestrel, and an estrogen called ethinyl estradiol. Birth control methods that have both an estrogen and a progestin are called combination hormonal contraceptives (CHCs).
Twirla: Alternatives, uses, side effects, and more - Medical News Today
2021年5月25日 · Twirla is a brand-name prescription patch that’s used as birth control. It’s FDA-approved to help prevent pregnancy in certain females* of any age who are able to become …
- 某些结果已被删除